FGF23–S129F mutant bypasses ER/Golgi to the circulation of hyperphosphatemic familial tumoral calcinosis patients
Abstract
No abstract availableKeywords
Funding Information
- Arabian Gulf University (R05)
This publication has 41 references indexed in Scilit:
- Regulation and Function of the FGF23/Klotho Endocrine PathwaysPhysiological Reviews, 2012
- The Unfolded Protein Response, Degradation from the Endoplasmic Reticulum, and CancerGenes & Cancer, 2010
- Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutationsAmerican Journal of Medical Genetics Part A, 2010
- In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Familial Tumoral Calcinosis: From Characterization of a Rare Phenotype to the Pathogenesis of Ectopic CalcificationJournal of Investigative Dermatology, 2010
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formationProceedings of the National Academy of Sciences, 2009
- Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral CalcinosisThe Journal of Clinical Endocrinology & Metabolism, 2009
- Signaling pathways utilized by PTH and dopamine to inhibit phosphate transport in mouse renal proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2009
- Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosisAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosisJournal of Clinical Investigation, 2007